|   1-(3-氯苯基)-4-甲基哌嗪结构式   | 常用名 | 1-(3-氯苯基)-4-甲基哌嗪 | 英文名 | Piperazine, 1-(3-chlorophenyl)-4-methyl- | 
|---|---|---|---|---|
| CAS号 | 20011-11-4 | 分子量 | 210.70300 | |
| 密度 | 1.140 g/cm3 | 沸点 | 315 °C at 760 mmHg | |
| 分子式 | C11H15ClN2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A | 
| 中文名 | 1-(3-氯苯基)-4-甲基-哌嗪 | 
|---|---|
| 英文名 | 1-(3-Chlorophenyl)-4-methylpiperazine | 
| 英文别名 | 更多 | 
| 密度 | 1.140 g/cm3 | 
|---|---|
| 沸点 | 315 °C at 760 mmHg | 
| 分子式 | C11H15ClN2 | 
| 分子量 | 210.70300 | 
| 精确质量 | 210.09200 | 
| PSA | 6.48000 | 
| LogP | 2.09470 | 
| 储存条件 | 室温, 密封, 干燥 | 
| 海关编码 | 2933599090 | 
|---|
| ~85%   1-(3-氯苯基)-4-甲基哌嗪 20011-11-4 | 
| 文献:Romanelli; Manetti; Scapecchi; Borea; Dei; Bartolini; Ghelardini; Gualtieri; Guandalini; Varani Journal of Medicinal Chemistry, 2001 , vol. 44, # 23 p. 3946 - 3955 | 
| ~%   1-(3-氯苯基)-4-甲基哌嗪 20011-11-4 | 
| 文献:Mokrosz; Pietrasiewicz; Duszynska; Cegla Journal of Medicinal Chemistry, 1992 , vol. 35, # 13 p. 2369 - 2374 | 
| ~36%   1-(3-氯苯基)-4-甲基哌嗪 20011-11-4 | 
| 文献:Brenner, Eric; Schneider, Raphael; Fort, Yves Tetrahedron, 1999 , vol. 55, # 44 p. 12829 - 12842 | 
| 1-(3-氯苯基)-4-甲基哌嗪上游产品 5 | |
|---|---|
| 1-(3-氯苯基)-4-甲基哌嗪下游产品 0 | |
| 海关编码 | 2933599090 | 
|---|---|
| 中文概述 | 2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% | 
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 | 
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% | 
| N-(m-Chlorophenyl)-N'-(2-pyridyl)harnstoff | 
| N-(3-chlorophenyl)-N'-(2-pyridyl)urea | 
| N-(m-Chlorphenyl)-N'-methyl-piperazin | 
| 1-<3-Chlor-phenyl>-4-methyl-piperazin | 
| 1-(3-chloro-phenyl)-3-pyridin-2-yl-urea | 
| 1-(3-chloro-phenyl)-4-methyl-piperazine |